行情

LGND

LGND

Ligand Pharma
NASDAQ

实时行情|Nasdaq Last Sale

88.54
-1.40
-1.56%
盘后: 88.54 0 0.00% 16:08 01/24 EST
开盘
90.33
昨收
89.94
最高
90.59
最低
87.85
成交量
34.25万
成交额
--
52周最高
130.50
52周最低
84.45
市值
16.83亿
市盈率(TTM)
3.184
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

LGND 新闻

  • 担忧污染饮用水德民众抗议特斯拉建厂 马斯克回应来了
  • 新浪美股.1小时前
  • 美国确诊第3例新型冠状病毒感染的肺炎病例
  • 中国新闻网.1小时前
  • 英国"脱欧"事务大臣:英国下个月将制定欧盟贸易目标
  • 新浪美股.2小时前
  • 离开武汉的500多万人都去了哪里?大数据告诉你
  • 第一财经日报.2小时前

更多

所属板块

生物技术和医学研究
-2.64%
制药与医学研究
-2.00%

热门股票

名称
价格
涨跌幅

LGND 简况

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work toward obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others.
展开

Webull提供Ligand Pharmaceuticals Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。